DrugPatentWatch Database Preview
Patent: 10,577,154
Summary for Patent: 10,577,154
| Title: | Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus |
| Abstract: | A method for providing a passivation layer or pH protective coating on a substrate surface by PECVD is provided, the method comprising generating a plasma from a gaseous reactant comprising polymerizing gases. The lubricity, passivation, pH protective, hydrophobicity, and/or barrier properties of the passivation layer or pH protective coating are set by setting the ratio of the O.sub.2 to the organosilicon precursor in the precursor feed, and/or by setting the electric power used for generating the plasma. In particular, a passivation layer or pH protective coating made by the method is provided. Pharmaceutical packages coated by the method and the use of such packages protecting composition contained in the vessel against mechanical and/or chemical effects of the surface of the package without a passivation layer or pH protective coating material are also provided. |
| Inventor(s): | Felts; John T. (Alameda, CA), Fisk; Thomas E. (Green Valley, AZ), Abrams; Robert S. (Albany, NY), Ferguson; John (Auburn, AL), Freedman; Jonathan R. (Auburn, AL), Pangborn; Robert J. (Harbor Springs, MI), Sagona; Peter J. (Pottstown, PA), Weikart; Christopher (Auburn, AL) |
| Assignee: | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) |
| Application Number: | 16/226,463 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,577,154
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | MYLOTARG | gemtuzumab ozogamicin | VIAL;SINGLE-DOSE | 761060 | 001 | 2018-04-09 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | RX | Orphan | search |
| Genentech Inc | OCREVUS | ocrelizumab | INJECTABLE;INJECTION | 761053 | 001 | 2017-03-28 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | RX | search | |
| Janssen Biotech | STELARA | ustekinumab | INJECTABLE;INJECTION | 761044 | 001 | 2019-11-07 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | RX | search | |
| Biogen | ZINBRYTA | daclizumab | INJECTABLE;INJECTION | 761029 | 001 | 2017-05-26 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
